Clinical Trials Sponsored by Nexgen Pharma, Inc
Total 2609 results
-
Nexgen Pharma, IncCompleted
-
Astellas Pharma IncSeagen Inc.CompletedMetastatic Urothelial CancerJapan
-
Astellas Pharma IncSeagen Inc.CompletedProstate NeoplasmsUnited States
-
Astellas Pharma IncSeagen Inc.CompletedUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Korea, Republic of, Spain, France, Germany, Italy, Japan, Netherlands
-
Nexgen Pharma, IncPharmaceutical Research Unit, JordanCompleted
-
Astellas Pharma Korea, Inc.Seagen Inc.RecruitingUrothelial CancerKorea, Republic of
-
Astellas Pharma China, Inc.Seagen Inc.Active, not recruitingMetastatic Urothelial CancerChina
-
Astellas Pharma Global Development, Inc.Seagen Inc.Active, not recruitingBladder Cancer | Urothelial Cancer | Ureteral CancerUnited States, Japan, Korea, Republic of, Taiwan, Argentina, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, Switzerland, United Kingdom
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial Cancer and Other Malignant Solid TumorsUnited States, Canada
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial CancerUnited States, Canada
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
Astellas Pharma IncSeagen Inc.; Agensys, Inc.CompletedNeoplasms | Tumors | Medical OncologyUnited States, Canada
-
NervGen PharmaCompleted
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom
-
NervGen PharmaRecruitingSpinal Cord Injuries | Chronic Spinal Cord Injury | Subacute Spinal Cord InjuryUnited States
-
Nexgen Dermatologics, Inc.Unknown
-
Nexgen Dermatologics, Inc.Unknown
-
Evgen PharmaCompleted
-
NeXtGen Biologics, Inc.Completed
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingUrothelial CancerUnited States, Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Singapore, Spain, Switzerland, Taiwan, Thailand and more
-
Merck Sharp & Dohme LLCAstellas Pharma Inc; Seagen Inc.Active, not recruitingBladder CancerHungary, United States, China, Argentina, Australia, Bulgaria, Canada, Colombia, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Malaysia, Philippines, Poland, Portugal, Romania, Russian Federation, Singapo... and more
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.Active, not recruitingUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Italy, Spain, Canada, France, Puerto Rico
-
Memgen, LLCCompleted
-
Memgen, LLCCompletedChronic Lymphocytic LeukemiaUnited States
-
PepGen IncRecruitingMyotonic Dystrophy 1United States, Canada
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
PepGen IncRecruitingDuchenne Muscular DystrophyCanada
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell LungUnited States, Belgium, Poland, Spain, Hungary, France
-
Seagen Inc.RecruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Gastric Cancer | Ovarian Neoplasms | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Neoplasms | Esophageal Squamous Cell CarcinomaUnited States, Spain, Italy, Canada, United Kingdom, France, Belgium, Germany, Netherlands
-
Seagen Inc.RecruitingAcute Myeloid Leukemia | Myelodyspastic SyndromeUnited States, Netherlands
-
Seagen Inc.Active, not recruitingPeripheral T-cell LymphomaUnited States, Czechia, Italy, Spain, United Kingdom, France
-
Seagen Inc.Terminated
-
Seagen Inc.Active, not recruitingUrologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Carcinoma, Non-Small-Cell Lung | Biliary Tract Neoplasms | HER2 Mutations Breast NeoplasmsUnited States, United Kingdom, Spain, Korea, Republic of, Italy, Belgium, Germany, Japan, Netherlands, Poland
-
Seagen Inc.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Korea, Republic of, United Kingdom, Taiwan, Canada, Australia
-
Seagen Inc.CompletedHER2 Positive Breast CancersUnited States, Canada
-
Seagen Inc.TerminatedMultiple MyelomaUnited States
-
Seagen Inc.TerminatedCarcinoma, Renal Cell | Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Carcinoma, Squamous Cell of Head and Neck | Urinary Bladder NeoplasmUnited States
-
Seagen Inc.Completed
-
Seagen Inc.TerminatedDiffuse, Large B-Cell, Lymphoma | Follicular Lymphoma, Grade 3b | Transformed Lymphoma / DLBCLUnited States, Puerto Rico
-
Seagen Inc.TerminatedMyelodysplastic SyndromeUnited States
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Seagen Inc.TerminatedSystemic Lupus ErythematosusUnited States
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States
-
Seagen Inc.CompletedBurkitt Lymphoma | Precursor B-cell Lymphoblastic Leukemia-LymphomaUnited States
-
Seagen Inc.CompletedLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, T-CellUnited States, Canada